SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

NYSE:SEM • US81619Q1058

Current stock price

16.45 USD
+0.02 (+0.12%)
At close:
16.45 USD
0 (0%)
After Hours:

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SEM Profitability Analysis

1.1 Basic Checks

  • In the past year SEM was profitable.
  • In the past year SEM had a positive cash flow from operations.
  • In the past 5 years SEM has always been profitable.
  • In the past 5 years SEM always reported a positive cash flow from operatings.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • SEM's Return On Assets of 2.44% is in line compared to the rest of the industry. SEM outperforms 58.00% of its industry peers.
  • With a decent Return On Equity value of 8.38%, SEM is doing good in the industry, outperforming 64.00% of the companies in the same industry.
  • SEM has a Return On Invested Capital of 5.27%. This is comparable to the rest of the industry: SEM outperforms 58.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SEM is below the industry average of 8.43%.
  • The 3 year average ROIC (4.28%) for SEM is below the current ROIC(5.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SEM has a Profit Margin of 2.62%. This is in the better half of the industry: SEM outperforms 64.00% of its industry peers.
  • In the last couple of years the Profit Margin of SEM has declined.
  • Looking at the Operating Margin, with a value of 6.17%, SEM is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
  • SEM's Operating Margin has declined in the last couple of years.
  • SEM has a worse Gross Margin (11.54%) than 71.00% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

2

2. SEM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • SEM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SEM has been reduced compared to 5 years ago.
  • SEM has a worse debt/assets ratio than last year.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.63, we must say that SEM is in the distress zone and has some risk of bankruptcy.
  • SEM has a Altman-Z score (1.63) which is in line with its industry peers.
  • The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 15.74, SEM is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.07 is on the high side and indicates that SEM has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.07, SEM is not doing good in the industry: 63.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.63
ROIC/WACC0.6
WACC8.74%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a worse Current ratio (1.04) than 69.00% of its industry peers.
  • SEM has a Quick Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • SEM's Quick ratio of 1.04 is on the low side compared to the rest of the industry. SEM is outperformed by 63.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

3

3. SEM Growth Analysis

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • The Earnings Per Share has been decreasing by -9.36% on average over the past years.
  • SEM shows a small growth in Revenue. In the last year, the Revenue has grown by 5.12%.
  • The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.71% on average over the next years.
  • Based on estimates for the next years, SEM will show a small growth in Revenue. The Revenue will grow by 4.75% on average per year.
EPS Next Y11.25%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

5

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.30, which indicates a correct valuation of SEM.
  • Based on the Price/Earnings ratio, SEM is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
  • SEM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
  • Based on the Price/Forward Earnings ratio of 12.86, the valuation of SEM can be described as correct.
  • SEM's Price/Forward Earnings ratio is rather cheap when compared to the industry. SEM is cheaper than 82.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.29. SEM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.3
Fwd PE 12.86
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SEM is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 67.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.4
EV/EBITDA 8.06
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y9.53%
EPS Next 3Y3.71%

5

5. SEM Dividend Analysis

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.52%.
  • Compared to an average industry Dividend Yield of 0.46, SEM pays a better dividend. On top of this SEM pays more dividend than 89.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 21.99% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP21.99%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (4/24/2026, 8:08:01 PM)

After market: 16.45 0 (0%)

16.45

+0.02 (+0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners83.08%
Inst Owner Change1.14%
Ins Owners10.75%
Ins Owner Change0.41%
Market Cap2.04B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts71.11
Price Target17.03 (3.53%)
Short Float %2.63%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-4.75%
PT rev (3m)-8.07%
EPS NQ rev (1m)0.84%
EPS NQ rev (3m)5.51%
EPS NY rev (1m)-2%
EPS NY rev (3m)-3.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 14.3
Fwd PE 12.86
P/S 0.37
P/FCF 17.4
P/OCF 5.89
P/B 1.2
P/tB N/A
EV/EBITDA 8.06
EPS(TTM)1.15
EY6.99%
EPS(NY)1.28
Fwd EY7.78%
FCF(TTM)0.95
FCFY5.75%
OCF(TTM)2.79
OCFY16.98%
SpS43.97
BVpS13.75
TBVpS-6.1
PEG (NY)1.27
PEG (5Y)N/A
Graham Number18.8639 (14.67%)
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.63
F-Score5
WACC8.74%
ROIC/WACC0.6
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y11.25%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year40.13%
EBIT Next 3Y15.67%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 5 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


What is the profitability of SEM stock?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What is the earnings growth outlook for SELECT MEDICAL HOLDINGS CORP?

The Earnings per Share (EPS) of SELECT MEDICAL HOLDINGS CORP (SEM) is expected to grow by 11.25% in the next year.


Can you provide the dividend sustainability for SEM stock?

The dividend rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 5 / 10 and the dividend payout ratio is 21.99%.